DOCSLIB.ORG

28-0.4 List of Participants

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
28-0.4 List of Participants 28th Stop TB Partnership Coordinating Board DOC: 28-0.4 Pre-briefings 18 September 2016 and Meeting 19-20 September 2016 List of Participants, alphabetical by last name (provisional: dated 15 September 2016) Title Name Organisation Position Country Group Dr Aaron Motsoaledi Ministry of Health Minister of Health South Africa Coordinating Board Chair Dr Joanne Carter RESULTS Educational Fund Executive Director United States of America Coordinating Board Vice-Chair list of participants by last name: Dr Nazira Karimo Vali Abdula Ministry of Health Minister of Health Mozambique Coordinating Board Member Mr Timur Abdullaev Community Representative Independent Consultant Uzbekistan Coordinating Board Member Mr Christopher Adasiewicz Global Health Strategies Senior Vice President United States of America Special Guest Dr Isaac Folorunso Adewole Federal Ministry of Health Minister of Health Federal Republic of Nigeria Special Guest Mr Chibuike Amaechi The Good Neighbour Chief Executive Officer Federal Republic of Nigeria Developing Country NGO Constituency Delegation Ms Mercy Annapoorni Rainbow TB Forum Founder & Trustee India TB Affected Communities Constituency Delegation Dr Denise Arakaki Ministry of Health General Coordinator, Brazil Coordinating Board Member Alternate TB Control National Program Ms Erika Arthun Bill & Melinda Gates Foundation Interim Chief of Staff, Senior Program Officer United States of America Coordinating Board Member Global Policy and Advocacy Dr Michèle Boccoz The Ministry of Foreign Affairs and Ambassador for the fight against HIV/AIDS France Special Guest International Development and Communicable Disesases Mr Mikkel Broholt United Nations Office for Project Services Portfolio Manager Switzerland Coordinating Board Member Alternate (UNOPS) Mr David Bryden RESULTS TB Advocacy Officer United States of America Developed Country NGO Constituency Delegation HE Mrs Aisha Muhammadu Buhari Federal Republic of Nigeria Wife of the President, Federal Republic of Nigeria Special Guest Federal Republic of Nigeria Mr Armen Chobanyan United Nations Office for Project Services Head of Programme Switzerland Coordinating Board Member (UNOPS) Title Name Organisation Position Country Group Ms Delia Clayton RESULTS Educational Fund Office of the Vice-Chair of the Stop TB United States of America Special Guest Partnership Coordinating Board Dr Vivian Cox DR-TB STAT Task Force incoming Chair United States of America Special Guest Ms Jane Coyne UN Secretary-General’s Special Envoy on Director of TB Programs United States of America Special Guest Tuberculosis Dr Charles Daley National Jewish Health Chief, Division of Mycobacterial and United States of America Coordinating Board Member Respiratory Infections Dr Philippe Douste-Blazy United Nations Special Advisor to the United Nations Secretary France Special Guest General on Innovative Finance for Development Dr Jiří Dvořák International Federation of Football Chief Medical Officer Switzerland Special Guest Association (FIFA) Dr Mark Dybul The Global Fund to Fight HIV/AIDS Executive Director Switzerland Coordinating Board Member Tuberculosis and Malaria Ms Dara Erck Aeras Vice-President, External Relations United States of America Special Guest Dr Alexandre Fonseca Ministry of Health Chief of Staff, Secretariat of Health Brazil Coordinating Board Member ad int dos Santos Surveillance Ms Carrie Fritschy We are TB Founder United States of America Special Guest Dr Jennifer Furin DR-TB STAT Task Force Chair United States of America Special Guest Lecturer, Harvard Medical School Ms Lucy Ghati Kenya Ethical and Legal Issues Network TB & HIV Focal Point Kenya Developing Country NGO Constituency Delegation Dr Tedros Adhanom Ministry of Foreign Affairs Minister of Foreign Affairs Federal Democratic Republic of Special Guest Ghebreyesus Ethiopia Dr Eric Goosby United Nations United Nations Secretary General’s Special United States of America Special Guest Envoy on Tuberculosis Mr Nick Herbert Global TB Caucus Member of Parliament United Kingdom Special Guest Mr Andrew Jack Financial Times Editor, curated content United Kingdom Special Guest Mr Vama Jele Southern Africa Miners Association (SAMA) Executive Secretary Lesotho TB Affected Communities Constituency Delegation Dr Cassandra Kelly-Cirino DNA Genotek Vice President, Infectious Diseases Canada Private Sector Constituency Delegation Mr Alex Kendall Global Health Strategies Director United States of America Private Sector Constituency Delegation Dr Sunil Khaparde Ministry of Health and Family Welfare NTP Manager India Coordinating Board Member Alternate Title Name Organisation Position Country Group Dr Celeste Kinsey Global Affairs Canada Director, Global Health Division Canada Coordinating Board Member Ms Blessi Kumar Global Coalition of TB Activists (GCTA) Health Activist & Public India Special Guest Health Consultant Dr Lovett Lawson Stop TB Partnership Nigeria Chairman Federal Republic of Nigeria Special Guest Dr Evan Lee Eli Lilly Export SA Vice President, Global Health Programs and Switzerland Coordinating Board Member HC Access Dr David Lewinsohn Working Group on New TB Vaccines Chair United States of America Coordinating Board Member Dr Stephen Lewis AIDS-Free World Director Canada Special Guest Mr Jose Luiz Castro International Union Against Tuberculosis and Executive Director France Coordinating Board Member Lung Disease (The Union) Dr Susan Maloney Centers for Disease Control and Prevention CDC Global TB Coordinator United States of America Coordinating Board Member Mr Lerole David Mametja Ministry of Health NTP Manager South Africa Special Guest Dr Ivan Manhiça Ministry of Health National Deputy Director of Public Health Mozambique Coordinating Board Member Alternate Mr Lelio Marmora UNITAID Executive Director Switzerland Coordinating Board Member Mr Melecio Mayta Cota Asociación de Personas Afectadas por President Peru TB Affected Communities Constituency Tuberculosis del Peru (ASPAT Peru) Delegation Ms Betsy McKay Wall Street Journal Press United States of America Special Guest Ms Lindsay McKenna Treatment Action Group TB/HIV Project Officer United States of America Developed Country NGO Constituency Delegation Mr Subrat Mohanty International Union Against Tuberculosis and Project Coordinator South East Asia Office Developing Country NGO Constituency Lung Disease (The Union) Delegation Ms Nuala Moore American Thoracic Society/Stop TB USA Associate Director United States of America Developed Country NGO Constituency Delegation Dr David Nabarro United Nations United Nations Secretary-General's Special United States of America Special Guest Adviser on the 2030 Agenda for Sustainable Development and Climate Change Dr Partha Nandi WXYZ ABC Detroit Chief Health Editor United States of America Special Guest Dr Sania Nishtar Heartfile Founder and President Pakistan Special Guest Title Name Organisation Position Country Group Ms Kate O'Brien CBS Press United States of America Special Guest Mr Jim O’Neill Review on Antimicrobial Resistance Chair United Kingdom Special Guest Mr Austin Arinze Obiefuna Afro Global Alliance Executive Director Ghana Coordinating Board Member Mr Aaron Oxley RESULTS UK Executive Director United Kingdom Coordinating Board Member Dr Ariel Pablos-Méndez US Agency for International Development Assistant Administrator for Global Health, United States of America Coordinating Board Member Child and Maternal Survival Coordinator Dr Madhukar Pai McGill International TB Centre Canada Research Chair in Epidemiology & Canada Special Guest Global Health Director Mr Bruno Pereira Rezende Ministry of Health Deputy Head, International affairs office Brazil Special Guest Ms Thoko Phiri-Nkhoma Facilitators of Community Transformation Executive Director Malawi Coordinating Board Member (FACT) Dr Victor Ramathesele Ministry of Health Advisor to the Chair of the Coordinating South Africa Special Guest Board Dr Mario Raviglione World Health Organization Director, Global TB Programme Switzerland Coordinating Board Member Dr Minghui Ren World Health Organization Assistant Director General, HIV/AIDS, TB, Switzerland Coordinating Board Member Alternate Malaria and Neglected Tropical Diseases Mr Navdeep Rinwa Ministry of Health and Family Welfare Joint Secretary Health & Family Welfare India Coordinating Board Member Mr Bruno Rivalan Global Health Advocates Head of French Office France Special Guest Ms Miriam Schneidman World Bank Lead Health Specialist United States of America Coordinating Board Member Ms Nina Schwalbe Spark Street Consulting Consultant United States of America Special Guest Ms Cherise Scott TB Alliance Director, Pediatric Programs United States of America Special Guest Mr Michel Sidibé Joint United Nations Programme on HIV/AIDS Executive Director Switzerland Coordinating Board Member Ms Mandy Slutsker ACTION Global Health Advocacy Partnership Manager, Policy and Advocacy United States of America Developed Country NGO Constituency Delegation Dr Melvin Spiegelman TB Alliance President and Chief Executive Officer United States of America Special Guest Dr Christian Stoeckigt Siemens Healthcare Diagnostics Products Head, Global Clinical & Scientific Marketing Germany Private Sector Constituency Delegation GmbH Title Name Organisation Position Country Group Dr Eliud Wandwalo The Global Fund to Fight HIV/AIDS Senior Specialist for Tuberculosis Switzerland Coordinating Board Member Alternate Tuberculosis and Malaria Dr Kitty Van Weezenbeek KNCV Tuberculosis Foundation Executive Director Netherlands Coordinating Board
Load more

Recommended publications
  • LGCW Event Summary Report
    LGCW Event Summary Report Policy Event The first of the two London Global Cancer Week events was focused on the review and development of policy around prevention and treatment of the disease. The Rt Hon. Patricia Scotland opened the meeting then handed the reigns to Dr Osahon Enabulule, president of the Commonwealth Medical Association, who acted as chair. The event attracted eminent people such as HRH Princess Dina Mired of Jordan whose powerful keynote speech focused on how cervical cancer elimination in the Commonwealth could pave the way for more efficient health systems, and solutions to the challenges posed by other cancers and non-communicable diseases. She also highlighted the opportunities to strengthen implementation of Universal Health Coverage. In her presentation, Dr Miriam Mutebi, chair of the board for the Union of International Cancer Control (UICC), focused on the implementation of the World Health Organisation’s (WHO) global strategy and the life course approach for cervical cancer elimination. Dr Freddy Bray, head of Cancer Surveillance Section at the International Agency for Research on Cancer (IARC), gave an overview of cancer prevalence and trends in the Commonwealth, and discussed the importance of predominant cancer surveillance mechanisms in Africa. Mark Lodge, Convenor of London Global Cancer Week (LGCW) and director of International Network for Cancer Treatment and Research, provided the audience with the vision and holistic overview of LGCW 2020. Rwandan minister of health, Hon. Daniel Ngamije, Guyanese minister of health Hon Dr Anthony Frank and Zambia’s permanent secretary, Dr Kennedy Malama outlined their countries’ efforts toward cervical cancer elimination and the management and control of other types of cancers.
    [Show full text]
  • The Case for Collective Commonwealth Action on Cervical Cancer
    GLOBAL CANCER INITIATIVES The case for collective Commonwealth action on cervical cancer Professor Isaac F Adewole (left), Gynaecologic Oncology Unit, Department of Obstetrics and Gynaecology, College of Medicine, University of Ibadan, Nigeria and Dr Ophira Ginsburg (right), High-Risk Cancer Genetics Program, Perlmutter Cancer Center, School for Global Health, Department of Population health, New York School of Medicine, New York, USA Cervical cancer remains a public health challenge, particularly in the low-income and middle-income countries (LMICs) of the Commonwealth due to inequity, injustice and ignorance. The stark reality is that the global call by the World Health Organization (WHO) for the elimination of cervical cancer is only feasible in a few Commonwealth member countries. However, robust collective action that is driven by the highest political leadership could create a pathway for countries with a high burden of cervical cancer and weak health infrastructure to meet the 2030 targets of the cervical cancer elimination agenda. Thus, there is the need for genuine partnerships in research, and policies that will fit the local needs of individual countries. Indeed, single dose HPV vaccination with a “screen and treat” approach for those with premalignant cervical diseases may be a good alternative strategy to the conventional protocol in most Commonwealth countries. It is important that member countries should support each other to generate local evidence, health workforce development, infrastructure and healthcare financing for cervical cancer prevention and treatment. This will ensure that no one is left behind. The time for action is now. Cervical cancer as a public health concern Effective cervical cancer strategy prevention and Cervical cancer, the second most common cancer among control is available women after breast cancer globally, has been described as Generally, persistence of high-risk human papillomavirus a disease that manifests inequity, injustice, and ignorance (HPV) infection is a necessary cause of cervical cancer, (1).
    [Show full text]
  • 'The Art & Science of Fundraising'
    ‘The Art & Science of Fundraising’ A Study Visit to New York for Executives from African Universities and Cultural Institutions New York City Funded through the generous support of List of participants in the 2013 to 2018 study visit programs (Titles and affiliations as of year of participation) Prof. Otlogetswe Totolo, Vice-Chancellor, Botswana International University of Science & Technology, Botswana, 2016 Prof. Thabo Fako, Vice-Chancellor, University of Botswana, Botswana, 2013 Mr. Dawid B. Katzke, Deputy Vice-Chancellor, Finance & Administration, University of Botswana, Botswana, 2013 Dr. Baagi T. Mmereki, Director, University of Botswana Foundation, University of Botswana, Botswana, 2013 Ms. Pamela Khumbah, Director, Office of Advancement & Development, Catholic University Institute of Buea, Cameroon, 2016 Prof. Edward Oben Ako, Rector, University of Maroua, Cameroon, 2017 Ms. Djalita Fialho, Board Member, Pedro Pires Leadership Institute, Cape Verde, 2018 Amb. Honorat Emmanuel Koffi-Abeni, International Relations Advisor, MDE Business School (IHE-Afrique), Côte d'Ivoire, 2017 Mr. Didier Raux-Yao, Chief of Finance and Fundraising Officer, MDE Business School (IHE-Afrique), Côte d'Ivoire, 2017 Prof. Saliou Toure, President, International University of Grand-Bassam, Côte d'Ivoire, 2018 Mr. Samuel Koffi, Chief Operating Officer, International University of Grand-Bassam, Côte d'Ivoire, 2018 Ms. Ramatou Coulibaly-Gauze, Dir. of Admin. & Finance, International University of Grand-Bassam, Côte d'Ivoire, 2018 Prof. Léonard Santedi Kinkupu, Rector, Catholic University of Congo, Democratic Republic of Congo, 2017 Dr. Ese Diejomaoh, Projects Coordinator, Centre Congolais de Culture de Formation et de Développement, Democratic Republic of Congo, 2016 Ms. Nicole Muyulu, Nurse Educator & Hygienist, Centre Congolais de Culture de Formation et de Développement, Democratic Republic of Congo, 2016 Prof.
    [Show full text]
  • 2014/2015 Audit Manual
    © Internal Audit Department First Edition 2014 Published by The Internal Audit Department, University of Ibadan UNIVERSITY OF IBADAN IBADAN, NIGERIA All rights reserved. No part of this publication may be reproduced, photocopied, transmitted in any form or by means, electronic or mechanical, audio or video recording, or any information, storage and AUDIT retrieval system without the written permissions of the publisher. MANUAL ISBN: Issued by the Internal Audit Department March, 2014 Printed at Ibadan University Printery Audit Manual Audit Manual Foreword It is apposite at this juncture to appreciate the efforts of the members of the Audit Manual Committees led by the Director, This Internal Audit Manual is a revised version of the 2006 Mr. B.O. Akinremi. Others include Mr. K.A. Davidson, edition. It is in furtherance of the Quality Assurance effort of Mr. A. L. O. Faniran, Mr. O. J. Folorunso, Mrs. O. O. Omisore, the Internal Audit Department of the University of Ibadan Mrs. Y. O. Efuntoye, Mr. R. O. Ibironke, Mrs. C. O. Ogunwole and under the leadership of the current Director of Audit, Mrs. A. A. Atanda. Mr. Babs O. Akinremi. Special appreciation also goes to Professors Kabiru Isyaku, The manual contains 10 chapters. Chapter one presents an B. O. Oke, Labode Popoola and M. O. Abatan, introduction; comprising the definition, objectives and Dr. G. A. Adeniran, Ambassador L. A. Shunni, Prof. J. B. Salka, responsibilities of the Internal Audit Department of the Prof. A. Soyibo and Prof. Kassey Garba, present and past University. It also gives an overview of the organization of the internal and external members of the Governing Council of the Department.
    [Show full text]
  • A Critical Evaluation of Cancer Care in Nigeria, Comparative Analysis to Other Countries, and Customization Of
    2019 , Engineering in By OF NIGERIA NICOSIA Biomedical NUHU ABDULHAQQNUHU ISA NEAR EAST UNIVERSITY EAST NEAR the Degree of Master the Science Degree of of DARD CANCER CAREDARD CANCER FOR SYSTEM SCHOOL OF APPLIED SCIENCES SCHOOL OF COUNTRIES, OF CUSTOMIZATION COUNTRIES, AND In Partial Fulfillment of the Requirements for Partial of Requirements In Fulfillment the STAN A THESIS SUBMITTED TO GRADUATE A THESIS THE NIGERIA, COMPARATIVE NIGERIA, TO ANALYSIS OTHER A CRITICAL A CRITICAL IN EVALUATION OF CANCER CARE NUHU ABDULHAQQ ISA A CRITICAL EVALUATION OF CANCER CARE IN NIGERIA, NEU COMPARATIVE ANALYSIS TO OTHER COUNTRIES, 2019 AND CUSTOMIZATION OF STANDARD CANCER CARE SYSTEM FOR NIGERIA A CRITICAL EVALUATION OF CANCER CARE IN NIGERIA, COMPARATIVE ANALYSIS TO OTHER COUNTRIES, AND CUSTOMIZATION OF STANDARD CANCER CARE SYSTEM FOR NIGERIA A THESIS SUBMITTED TO THE GRADUATE SCHOOL OF APPLIED SCIENCES OF NEAR EAST UNIVERSITY By NUHU ABDULHAQQ ISA In Partial Fulfillment of the Requirements for the Degree of Master of Science in Biomedical Engineering NICOSIA, 2019 I hereby declare that all information in this document has been obtained and presented in accordance with academic rules and ethical conduct. I also declare that, as required by these rules and conduct, I have fully cited and referenced all material and results that are not original to this work. Name, Last name: Signature: Date To all Victims of Cancer in Nigeria and the World ACKNOWLEDGEMENT My first appreciation goes to the Allah first who has given me good health and strength for a successful completion of my thesis program. I will like to thank my family for their continuous support and encouragement since the inception of my undergraduate program in 2012 at near east university to the completion of my master program in 2019 in the same university.
    [Show full text]
  • Africa and Cancer: Preparing for the Next Epidemic
    AFRICA AND CANCER: PREPARING FOR THE NEXT EPIDEMIC Isaac Folorunso Adewole FAS A NAS public lecture delivered January 2012 INTRODUCTION 1.1 A Big Honour It is my singular honour to deliver this guest lecture to a distinguished audience under the auspices of the Nigerian Academy of Science (NAS). Essentially tagged first quarter lecture in 2012, it can be likened to a state of the Union Address to the nation through NAS. I am proud to be a fellow of the Nigerian Academy of Science (NAS), the foremost scientific organization in Nigeria with the aim of promoting the growth, acquisition, and dissemination of scientific knowledge and to facilitate its use in solving of major problems of national interest. I am also aware that our President is likely, Dr. Goodluck Jonathan, GCFR, to assume office as the next Chair of the African Union and have taken the liberty as President of the African Organisation for Research and Training in Cancer (AORTIC) to deliver a sermon on Cancer to Africa on this occasion. I thank the President, Prof Oye Ibidapo-Obe FAS,and the entire fellows of the Acad- emy for the honour bestowed on me. I also thank my Chairman, Chief Wole Olanipekun SAN, who graciously accepted to chair this occasion at such notice despite his busy schedule. 1.2 Africa in brief Africa is the world’s second largest and second most populous continent, after Asia. Africa with a landmass of about 30.2 million km2 (11.7 million sq mi) includ- ing adjacent islands, covers 6% of the Earth’s total surface area and 20.4% of the total land area.
    [Show full text]
  • March 24Th Programme Version 12
    Nigerian Academy of Medicine (RC. 1586058) FORMAL Induction Ceremony OF FOUNDATION FELLOWS OF THE NIGERIAN ACADEMY OF MEDICINE (RC. 1586058) (Virtually by ZOOM Video-Conferencing) Meeting ID: 649 4148 0975 Passcode: 829600 Wednesday, March 3, 2021 1 The National Anthem Arise, O compatriots, Nigeria’s call obey To serve our fatherland With love and strength and faith The labours of our heroes past Shall never be in vain. To serve with heart and might One nation bound in freedom, peace and unity. Oh God of creation, direct our noble cause; Guide thou our leaders right, Help our Youth the truth to know In love and honesty to grow And living just and true Great lofty heights attain To build a nation where peace and justice Shall reign. The National Pledge I pledge to Nigeria, my country To be faithful, loyal and honest To serve Nigeria with all my strength To defend her Unity And uphold her honour and glory So help me God. 2 FOUNDATION FELLOWS OF NIGERIAN ACADEMY OF MEDICINE A. Members of Board of Trustees 1. Odugbemi, Tolu - Chairman 2. Adewole, Isaac F. 3. Azubuike, Jonathan C. 4. Oduntan, S. Olu 5. Idoko, John A. 6. Ohaeri, Jude Uzoma 7. Briggs, Nimi Dimkpa 8. Majekodunmi, Ajesola A. 9. Dogo, Dilli 10. Jeboda, Sonny O. B. Other Foundation Fellows 47. Ogedengbe, Olasurubomi 11. Adebonojo, Samuel A. 48. Ogunbiyi, Obasina A. 12. Aghaji, Martin A. C. 49. Ogunbiyi, J. Olufemi 13. Akande, E. Oluwole 50. Ogunbodede, Eyitope O. 14. Akanji, Abayomi O. 51. Ogunniyi, Adesola 15. Akinsete, Ibironke 52. Ogunsola, Folashade T.
    [Show full text]
  • Read Pdf Copy
    Journal of the International Association of Providers of AIDS Care (JIAPAC) http://jia.sagepub.com/ Dyslipidemia in ART-Naive HIV-Infected Persons in Nigeria−−Implications for Care Modupe Akinrele Kuti, Olubukola Adeponle Adesina, Oluwatosin Alaba Awolude, Babatunde Oluwatosin Ogunbosi, Samuel Adetona Fayemiwo, Joshua Odunayo Akinyemi, Adedotun Adeyinka Adetunji, Achiaka Emmanuelle Irabor, Georgina Njideka Odaibo, Okonkwo Prosper, Babafemi Olapoju Taiwo, David Olaleye, Robert L. Murphy, Phyllis Kanki and Isaac Folorunso Adewole Journal of the International Association of Providers of AIDS Care (JIAPAC) published online 20 October 2014 DOI: 10.1177/2325957414555227 The online version of this article can be found at: http://jia.sagepub.com/content/early/2014/10/15/2325957414555227 Published by: http://www.sagepublications.com On behalf of: International Association of Physicians in AIDS Care Additional services and information for Journal of the International Association of Providers of AIDS Care (JIAPAC) can be found at: Email Alerts: http://jia.sagepub.com/cgi/alerts Subscriptions: http://jia.sagepub.com/subscriptions Reprints: http://www.sagepub.com/journalsReprints.nav Permissions: http://www.sagepub.com/journalsPermissions.nav >> OnlineFirst Version of Record - Oct 20, 2014 What is This? Downloaded from jia.sagepub.com by guest on October 21, 2014 Original Manuscript Journal of the International Association of Providers of AIDS Care 1–5 Dyslipidemia in ART-Naive HIV-Infected ª The Author(s) 2014 Reprints and permission: Persons in Nigeria—Implications for Care sagepub.com/journalsPermissions.nav DOI: 10.1177/2325957414555227 jiapac.sagepub.com Modupe Akinrele Kuti1, Olubukola Adeponle Adesina2, Oluwatosin Alaba Awolude2, Babatunde Oluwatosin Ogunbosi3, Samuel Adetona Fayemiwo4, Joshua Odunayo Akinyemi5, Adedotun Adeyinka Adetunji6, Achiaka Emmanuelle Irabor6, Georgina Njideka Odaibo7, Okonkwo Prosper8, Babafemi Olapoju Taiwo9, David Olaleye7, Robert L.
    [Show full text]
  • ASCO Resource Stratified Guidelines Primary Prevention of Cervical
    Lead Group Edward L. Trimble, MD, MPH Log US National Cancer Institute ASCO Resource Stratified Guidelines Primary Prevention of Cervical Cancer Secondary Prevention of Cervical Cancer Management of Women with Invasive Cervical Cancer American Society of Clinical Oncology • Founded in 1965; multidiscisplinary professional society; 44,000 members • 40% of members from outside US; 50% of annual meeting attendees from outside US • Growing commitment to global oncology – Journal of Global Oncology – Global cancer track at annual meeting – Grants for global oncology projects Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline www.asco.org/rs-cervical-cancer-primary-prev-guideline ©American Society of Clinical Oncology 2017. All rights reserved. Secondary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline www.asco.org/rs-cervical-cancer-secondary-prev-guideline ©American Society of Clinical Oncology 2016. All rights reserved. Management and Care of Women with Invasive Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Clinical Practice Guideline www.asco.org/rs-cervical-cancer-treatment-guideline ©American Society of Clinical Oncology 2016. All rights reserved. Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline www.asco.org/rs-cervical-cancer-primary-prev-guideline ©American Society of Clinical Oncology 2017. All rights reserved. Introduction • Approximately 85% of incident cervical cancers occur in less developed regions, often overlapping with low- and middle-income countries (LMICs) around the world, and represent 12% of cancers among women in those regions. • HPV causes virtually all cervical cancer and its immediate precursors everywhere in the world.
    [Show full text]
  • Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline
    Primary Prevention of Cervical Cancer: American Society of Clinical Oncology Resource-Stratified Guideline www.asco.org/rs-cervical-cancer-primary-prev-guideline ©American Society of Clinical Oncology 2017. All rights reserved. Introduction • Approximately 85% of incident cervical cancers occur in less developed regions, often overlapping with low- and middle-income countries (LMICs) around the world, and represent 12% of cancers among women in those regions. • HPV causes virtually all cervical cancer and its immediate precursors everywhere in the world. The HPV 16 and HPV 18 subtypes are most associated with cervical cancer. • The purpose of this guideline is to provide expert guidance on primary prevention, the reduction in human papillomavirus (HPV) infection by HPV vaccine administration, of cervical cancer to clinicians, public health leaders, and policymakers in all resource settings. www.asco.org/rs-cervical-cancer-primary-prev-guideline ©American Society of Clinical Oncology 2017. All rights reserved. ASCO Guideline Development Methodology The ASCO Clinical Practice Guidelines Committee guideline process includes: • a systematic literature review by ASCO guidelines staff • an expert panel provides critical review and evidence interpretation to inform guideline recommendations • final guideline approval by ASCO CPGC The full ASCO Guideline methodology supplement can be found at: www.asco.org/rs-cervical-cancer-primary-prev-guideline www.asco.org/rs-cervical-cancer-primary-prev-guideline ©American Society of Clinical Oncology 2017.
    [Show full text]
  • LONG-ACTING REVERSIBLE CONTRACEPTIVE (LARC) METHODS (Iuds and Contraceptive Implants)
    MANUAL FOR TRAINING DOCTORS AND NURSE/MIDWIVES ON LONG-ACTING REVERSIBLE CONTRACEPTIVE (LARC) METHODS (IUDs and Contraceptive Implants) ·Trainer's Manual 2015 FOREWORD The unacceptably poor maternal and child health indices in Nigeria have been of much concern to various governments at all levels in the country. In efforts to address these unfavorable indices, Family Planning which is one of the pillars of safe motherhood is being vigorously implemented through series of interventions. Notable amongst these, is the introduction of Task Shifting policy for Community Health Extension Workers, CHEWS to provide Injectables with mentoring for ensuring wider coverage of FP services in the country. The success being achieved led stakeholders to seek for Federal Government's approval for the provision of Long Acting Reversible Contraceptive Methods (IUDs and contraceptive Implants) which was approved by the National Council on Health in 2014. To this end the Federal Ministry of Health, Marie Stopes International Organisation Nigeria (MSION), Clinton Health Access Initiative (CHAI), United Nations Population Fund (UNFPA), and other partners met and developed a draft Training Manual, Participant Reference Book and Supervisory Checklist for impacting knowledge and skills on CHEWS to provide quality family planning services to clients who need IUDs and implant contraceptives. This intervention is expected to reduce the high unmet need for services and accelerate achievement of the target Family Planning Blueprint of 36 percent Contraceptive Prevalence Rate by the year 2018. The Federal Ministry of Health recognizes and appreciates all the development partners, especially Marie Stopes Nigeria, for their efforts in making all these interventions realizable and assures partners of government supports for further efforts at improving the health and well-being of our women and children in the country.
    [Show full text]
  • Conference Program
    CONFERENCE PROGRAM WEDNESDAY, JANUARY 18 Concurrent Sessions 1-2 15:00-16:30 Cervical Cancer Ballroom East Session Chair: Lynette Denny, University of Cape Town, Cape Town, South Africa Progress in scaling up cervical cancer prevention in health services of developing countries Rengaswamy Sankaranarayanan, International Agency for Research on Cancer, Lyon, France Title to be announced Isaac Folorunso Adewole, Federal Ministry of Health, Abuja, Nigeria The impact of premature death of women from preventable cancers, such as cervical cancer Lynette Denny Colorectal Cancer Ballroom West Session Chair: Raymond N. DuBois, Medical University of South Carolina, Charleston, SC The role of inflammation and DNA mismatch repair in colorectal cancer John M. Carethers, University of Michigan, Ann Arbor, MI Aspirin for precision chemoprevention of colorectal cancer Andrew T. Chan, Massachusetts General Hospital, Boston, MA Bacterially associated transcriptional remodelling in a distinct molecular subtype of colorectal cancer provides a plausible mechanistic basis for disease development and progression Katie Lennard, University of Cape Town, Cape Town, South Africa 16:30-17:00 Break Old Harbour Lobby 17:00-18:15 Welcome and Opening Remarks Grand Ballroom Welcome from AACR International Affairs Committee Chair Frank McCormick, UCSF Helen Diller Family Comprehensive Cancer Center, San Francisco, CA Welcome from Conference Cochair Peter A. Jones, Van Andel Research Institute, Grand Rapids, MI 17:30-18:15 Opening Keynote Lecture Grand Ballroom Session Chair:
    [Show full text]